Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3463824
Disease: MYELODYSPLASTIC SYNDROME
MYELODYSPLASTIC SYNDROME
0.010 Biomarker group BEFREE In conclusion, SNP-A can be used successfully in PB samples and the identification of CNA by SNP-A improve the diagnostic and prognostic evaluation of this group of MDS patients. 24123380 2013
CUI: C0238462
Disease: Medullary carcinoma of thyroid
Medullary carcinoma of thyroid
0.010 GeneticVariation disease BEFREE A significant higher prevalence of RET CNA was observed in RET mutated MTC (P=0.003). 21867742 2012
CUI: C0149925
Disease: Small cell carcinoma of lung
Small cell carcinoma of lung
0.010 AlteredExpression disease BEFREE The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis. 21785830 2011
Secondary malignant neoplasm of bone
0.010 AlteredExpression disease BEFREE The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis. 21785830 2011
CUI: C0278601
Disease: Inflammatory Breast Carcinoma
Inflammatory Breast Carcinoma
0.010 Biomarker disease BEFREE However, IBCs showed more frequent "complex" patterns and a higher percentage of genes with CNAs per sample. 21339811 2011
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.010 GeneticVariation phenotype BEFREE Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5'UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease. 20590401 2010
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.010 AlteredExpression disease LHGDN Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. 19034380 2009
CUI: C0003864
Disease: Arthritis
Arthritis
0.010 Biomarker disease BEFREE Virulence potential of the staphylococcal adhesin CNA in experimental arthritis is determined by its affinity for collagen. 15181582 2004
CUI: C0003869
Disease: Arthritis, Infectious
Arthritis, Infectious
0.010 Biomarker group BEFREE We examined the role of the collagen-binding function of CNA in a mouse model of septic arthritis by comparing the virulence of isogenic strains of S. aureus expressing (1) wild-type CNA, (2) a truncated form of CNA (CNA35) with a higher affinity for collagen than the wild type, (3) CNA35 containing a single point mutation resulting in loss of collagen binding, (4) CNA lacking the collagen-binding domain, and (5) the collagen-binding domain of ACE (adhesin of collagen from Enterococcus faecalis). 15181582 2004
CUI: C1692886
Disease: Arthritis, Bacterial
Arthritis, Bacterial
0.010 Biomarker group BEFREE We examined the role of the collagen-binding function of CNA in a mouse model of septic arthritis by comparing the virulence of isogenic strains of S. aureus expressing (1) wild-type CNA, (2) a truncated form of CNA (CNA35) with a higher affinity for collagen than the wild type, (3) CNA35 containing a single point mutation resulting in loss of collagen binding, (4) CNA lacking the collagen-binding domain, and (5) the collagen-binding domain of ACE (adhesin of collagen from Enterococcus faecalis). 15181582 2004
CUI: C1531553
Disease: Dendritic cell neoplasm
Dendritic cell neoplasm
0.010 Biomarker disease BEFREE The dendritic cell neoplasm exhibited reactivity with CNA-42, but nonreactivity for CD21, CD35, smooth muscle actin, desmin, and epithelial membrane antigen (EMA). 11127925 2000
Congenital contractural arachnodactyly
0.020 AlteredExpression disease BEFREE PPP3CA was expressed in the cytoplasm of carcinoma cells in 22 cases (24.2%) of 91 CCA patients. 31417643 2019
Congenital contractural arachnodactyly
0.020 Biomarker disease BEFREE Key genes of SOX2, KIT, PRSS56, WNT9A, SLC4A4, PRRG4, PANX2, PIR, RASSF8, MFSD4A, INS, RNF39, IL1R2, CST1, and PPP3CA might be potential prognostic markers for CCA, of which RNF39 and PRSS56 also showed significant correlation with clinical stage. 31687280 2019
CUI: C0432072
Disease: Dysmorphic features
Dysmorphic features
0.020 GeneticVariation disease BEFREE Recently de novo PPP3CA variants were reported as a cause of disease in 12 subjects presenting with epileptic encephalopathy and dysmorphic features. 30254215 2019
CUI: C0432072
Disease: Dysmorphic features
Dysmorphic features
0.020 GeneticVariation disease BEFREE By pooling genetic findings across multiple studies, we have identified six individuals with severe developmental delay (6/6), refractory seizures (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in PPP3CA. 28942967 2017
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
0.020 Biomarker disease BEFREE More importantly, the endogenous threonine 44 (T44)-phosphorylated form of C16orf74 interacted with the protein phosphatase 3 catalytic subunit alpha (PPP3CA) via the PDIIIT sequence in the PPP3CA-binding motif within the middle portion of C16orf74 in PDAC cells. 28881575 2017
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
0.020 AlteredExpression disease BEFREE LincRNA1611 and Ppp3ca were high expression in PDAC and may serve as new potential targets for intervention of the disease. 24469904 2015
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.020 GeneticVariation disease BEFREE Novel alternatively spliced isoforms of PPP3CA were identified and their expressions were found altered in brain regions of postmortem Alzheimer's disease patients. 20590401 2010
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.020 AlteredExpression disease LHGDN Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. 16150694 2005
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.030 Biomarker disease BEFREE Our results confirm the role of PPP3CA defects in pathogenesis of a distinct neurodevelopmental disorder including severe epilepsy and dysmorphism and provide further functional clues regarding the pathogenic mechanism. 30254215 2019
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.030 Biomarker disease BEFREE We confirmed PPP3CA as a substrate of the C2-lacking Nedd4-2 and showed that all three epilepsy-associated missense mutations of Nedd4-2 disrupted PPP3CA ubiquitination. 31357244 2019
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.030 Biomarker disease BEFREE Based on these findings, we securely implicate PPP3CA in early-onset refractory epilepsy and further support the emerging role for synaptic dysregulation in epilepsy. 28942967 2017
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.030 Biomarker disease BEFREE Survival differences of CIMP subtypes integrated with CNA information in human breast cancer. 28415743 2017
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.030 Biomarker disease BEFREE The oncogenetic tree model was built on CNV of ErbB2, AKT2, KRAS, PIK3CA, PTEN, and CCND1 genes in 963 cases of tumors with sequencing and CNA data of human breast cancer from TCGA. 27190992 2016
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.030 GeneticVariation disease BEFREE Even though an association of the polymorphisms rs2850328 and rs2395 and breast cancer was not detected in our case-control study population, other variants within the PPP3CA and MARK4 genes may still be associated with breast cancer, as both genes are implicated with processes involved in the disease as well as their mutual partaking in the Wnt signaling pathway. 22506312 2011